Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
logos LINCs Logo Mt Sinai Logo NIH Logo NCI Logo
Protein Page:
ACE (human)
rdtyret
p Phosphorylation
ac Acetylation
me Methylation
m1 Mono-methylation
m2 Di-methylation
m3 Tri-methylation
ub Ubiquitylation
sm Sumoylation
ne Neddylation
gl O-GlcNAc
ga O-GalNAc
pa Palmitoylation
ad Adenylation
sn S-Nitrosylation
ca Caspase cleavage
sc Succinylation

Overview
ACE Converts angiotensin I to angiotensin II by release of the terminal His-Leu, this results in an increase of the vasoconstrictor activity of angiotensin. Also able to inactivate bradykinin, a potent vasodilator. Has also a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. Genetic variations in ACE may be a cause of susceptibility to ischemic stroke (ISCHSTR); also known as cerebrovascular accident or cerebral infarction. A stroke is an acute neurologic event leading to death of neural tissue of the brain and resulting in loss of motor, sensory and/or cognitive function. Ischemic strokes, resulting from vascular occlusion, is considered to be a highly complex disease consisting of a group of heterogeneous disorders with multiple genetic and environmental risk factors. Defects in ACE are a cause of renal tubular dysgenesis (RTD). RTD is an autosomal recessive severe disorder of renal tubular development characterized by persistent fetal anuria and perinatal death, probably due to pulmonary hypoplasia from early-onset oligohydramnios (the Potter phenotype). Genetic variations in ACE are associated with susceptibility to microvascular complications of diabetes type 3 (MVCD3). These are pathological conditions that develop in numerous tissues and organs as a consequence of diabetes mellitus. They include diabetic retinopathy, diabetic nephropathy leading to end-stage renal disease, and diabetic neuropathy. Diabetic retinopathy remains the major cause of new- onset blindness among diabetic adults. It is characterized by vascular permeability and increased tissue ischemia and angiogenesis. Defects in ACE are a cause of susceptibility to intracerebral hemorrhage (ICH). A pathological condition characterized by bleeding into one or both cerebral hemispheres including the basal ganglia and the cerebral cortex. It is often associated with hypertension and craniocerebral trauma. Intracerebral bleeding is a common cause of stroke. Belongs to the peptidase M2 family. 4 isoforms of the human protein are produced by alternative splicing. Note: This description may include information from UniProtKB.
Protein type: Membrane protein, integral; EC 3.4.15.1; Protease
Chromosomal Location of Human Ortholog: 17q23.3
Cellular Component: endosome; external side of plasma membrane; extracellular region; extracellular space; integral to membrane; lysosome; plasma membrane
Molecular Function: actin binding; bradykinin receptor binding; carboxypeptidase activity; chloride ion binding; drug binding; endopeptidase activity; exopeptidase activity; metallopeptidase activity; mitogen-activated protein kinase binding; mitogen-activated protein kinase kinase binding; peptidyl-dipeptidase activity; protein binding; tripeptidyl-peptidase activity; zinc ion binding
Biological Process: angiotensin catabolic process in blood; angiotensin maturation; angiotensin mediated regulation of renal output; antigen processing and presentation of peptide antigen via MHC class I; arachidonic acid secretion; beta-amyloid metabolic process; blood vessel remodeling; cellular protein metabolic process; heart contraction; hormone catabolic process; kidney development; mononuclear cell proliferation; neutrophil mediated immunity; peptide catabolic process; regulation of angiotensin metabolic process; regulation of blood pressure; regulation of smooth muscle cell migration; regulation of systemic arterial blood pressure by renin-angiotensin; regulation of vasoconstriction; regulation of vasodilation; spermatogenesis
Disease: Alzheimer Disease; Hemorrhage, Intracerebral, Susceptibility To; Microvascular Complications Of Diabetes, Susceptibility To, 3; Renal Tubular Dysgenesis
Reference #:  P12821 (UniProtKB)
Alt. Names/Synonyms: ACE; ACE1; angiotensin converting enzyme, somatic isoform; angiotensin I converting enzyme (peptidyl-dipeptidase A) 1; angiotensin I converting enzyme 1; Angiotensin-converting enzyme; Angiotensin-converting enzyme, soluble form; carboxycathepsin; CD143; CD143 antigen; DCP; DCP1; dipeptidyl carboxypeptidase 1; Dipeptidyl carboxypeptidase I; Kininase II; MGC26566; MVCD3; peptidase P; testicular ECA
Gene Symbols: ACE
Molecular weight: 149,715 Da
Basal Isoelectric point: 5.95  Predict pI for various phosphorylation states
Select Structure to View Below

ACE

Protein Structure Not Found.


STRING  |  cBioPortal  |  Wikipedia  |  Reactome  |  neXtProt  |  Protein Atlas  |  BioGPS  |  Scansite  |  Pfam  |  RCSB PDB  |  ENZYME  |  Phospho3D  |  Phospho.ELM  |  NetworKIN  |  GeneCards  |  UniProtKB  |  Entrez-Gene  |  Ensembl Gene


Sites Implicated In
exocytosis, altered: S1299‑p
intracellular localization: S1299‑p
molecular association, regulation: S1299‑p
protein degradation: S1299‑p

Modification Sites and Domains  
Click here to view other types of protein modifications

Modification Sites in Parent Protein, Orthologs, and Isoforms  
 

Show Multiple Sequence Alignment


 LTP 

LTP: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 HTP 

HTP: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       human

► Hide Isoforms
 
0 1 Q99 EFAEAWGQKAKELYE
0 1 Q99 EFAEAWGQKAKELYE
0 1 K100 FAEAWGQKAKELYEP
0 1 K136‑ac SANLPLAkRQQyNAL
0 1 Y140‑p PLAkRQQyNALLSNM
0 1 Y151‑p LSNMSRIySTAKVCL
0 1 T697‑p NMQIANHtLKYGTQA
0 1 T716‑p VNQLQNTtIkRIIKK
0 1 K718‑ub QLQNTtIkRIIKKVQ
0 1 S824‑p GYVDAGDsWRSMYET
0 1 - gap
0 1 - gap
7 27 S1299‑p SHGPQFGsEVELRHS
0 2 S1306 sEVELRHS_______
  ACE iso2  
- gap
- gap
- gap
- gap
- gap
- gap
T123 NMQIANHTLKYGTQA
T142 VNQLQNTTIKRIIKK
K144 QLQNTTIKRIIKKVQ
S250 GYVDAGDSWRSMYET
Y700‑p GTREAPVyMSkRAAS
K703‑ac EAPVyMSkRAASSGP
- gap
- gap
  mouse

 
K104‑ac EFAEVWGkkAKELYE
K104 EFAEVWGKkAKELYE
K105‑ac FAEVWGkkAKELYES
Q141 PANLPLAQRQQYNSL
Y145 PLAQRQQYNSLLSNM
Y156 LSNMSRIYSTGKVCF
T702 STEVSNHTLKYGTRA
S721 VSNFQNSSIKRIIKK
K723 NFQNSSIKRIIKKLQ
S829 GYTDAGDSWRSLYES
- gap
- gap
S1305‑p HRGPQFGsEVELRHs
S1312‑p sEVELRHs_______
  rat

 
K105 EFAEVWGKKAKELYE
K105‑ub EFAEVWGkKAKELYE
K106 FAEVWGkKAKELYES
Q142 PANLPLTQRLQYNSL
Y146 PLTQRLQYNSLLSNM
Y157 LSNMSRIYSTGKVCF
T703 NKEVSNHTLKYGTWA
T722 VSNFQNSTIKRIIKK
K724 NFQNSTIKRIIKKVQ
S830 GYSDAGDSWRSSYES
- gap
- gap
S1306‑p HRGPQFGsEVELRHs
S1313‑p sEVELRHs_______
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.